André Revol

1.1k total citations
12 papers, 896 citations indexed

About

André Revol is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, André Revol has authored 12 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in André Revol's work include Lysosomal Storage Disorders Research (3 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). André Revol is often cited by papers focused on Lysosomal Storage Disorders Research (3 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). André Revol collaborates with scholars based in France, Germany and United States. André Revol's co-authors include Parviz Parvaz, Isabelle Garcia, E Bannier, Jocelyne Drai, Robert Rousson, Claire Rodriguez‐Lafrasse, Pierre Louisot, Marie T. Vanier, Peter G. Pentchev and Jacques Orgiazzi and has published in prestigious journals such as Clinica Chimica Acta, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Toxicology.

In The Last Decade

André Revol

12 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Revol France 10 372 226 123 111 101 12 896
Alessia Arcaro Italy 11 179 0.5× 393 1.7× 71 0.6× 49 0.4× 51 0.5× 33 1.0k
Paola Marcolongo Italy 26 206 0.6× 537 2.4× 106 0.9× 195 1.8× 149 1.5× 65 1.5k
Michael Burns United States 11 263 0.7× 321 1.4× 84 0.7× 64 0.6× 34 0.3× 17 812
Asoke G. Datta India 15 197 0.5× 296 1.3× 33 0.3× 78 0.7× 180 1.8× 56 846
Hideki Igisu Japan 23 395 1.1× 515 2.3× 110 0.9× 27 0.2× 49 0.5× 70 1.4k
Christelle Coatrieux France 9 178 0.5× 325 1.4× 74 0.6× 66 0.6× 78 0.8× 10 830
R Sotníková Slovakia 19 244 0.7× 274 1.2× 51 0.4× 153 1.4× 99 1.0× 73 964
Enrique Piña Mexico 20 263 0.7× 558 2.5× 36 0.3× 166 1.5× 143 1.4× 92 1.5k
Susan M. Deneke United States 11 157 0.4× 410 1.8× 104 0.8× 27 0.2× 232 2.3× 15 1.3k
Isabelle Garcia France 9 129 0.3× 133 0.6× 24 0.2× 96 0.9× 121 1.2× 14 614

Countries citing papers authored by André Revol

Since Specialization
Citations

This map shows the geographic impact of André Revol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Revol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Revol more than expected).

Fields of papers citing papers by André Revol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Revol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Revol. The network helps show where André Revol may publish in the future.

Co-authorship network of co-authors of André Revol

This figure shows the co-authorship network connecting the top 25 collaborators of André Revol. A scholar is included among the top collaborators of André Revol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Revol. André Revol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Drai, Jocelyne, et al.. (2002). Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clinica Chimica Acta. 321(1-2). 89–96. 161 indexed citations
2.
Leriche, A, et al.. (2001). Basic fibroblast growth factor and keratinocyte growth factor over-expression in benign prostatic hyperplasia. Il Farmaco. 56(5-7). 467–469. 9 indexed citations
4.
Drai, Jocelyne, et al.. (2001). Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts. Journal of Chromatography B Biomedical Sciences and Applications. 752(1). 123–132. 164 indexed citations
5.
Parvaz, Parviz, et al.. (2001). An evaluation of thiram toxicity on cultured human skin fibroblasts. Toxicology. 162(2). 89–101. 38 indexed citations
6.
Abidi, Hassane, et al.. (1999). Lipid Peroxidation and Antioxidant Defenses in Cystic Fibrosis Patients. Clinical Chemistry and Laboratory Medicine (CCLM). 37(5). 511–516. 46 indexed citations
7.
Nahoul, K, et al.. (1992). Determination of urinary cortisol with three commercial immunoassays. The Journal of Steroid Biochemistry and Molecular Biology. 43(6). 573–580. 14 indexed citations
8.
Garcia, Isabelle, et al.. (1991). Evaluation of the fructosamine test in obesity: consequences for the assessment of past glycemic control in diabetes. Clinical Biochemistry. 24(2). 203–209. 15 indexed citations
9.
Vanier, Marie T., Claire Rodriguez‐Lafrasse, Robert Rousson, et al.. (1991). Type C Niemann-Pick Disease: Biochemical Aspects and Phenotypic Heterogeneity. Developmental Neuroscience. 13(4-5). 307–314. 82 indexed citations
10.
Vanier, Marie T., Claire Rodriguez‐Lafrasse, Robert Rousson, et al.. (1991). Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1096(4). 328–337. 186 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026